Botulinum Toxin Type B in the Treatment of Cervical Dystonia: a Pilot Study
Authors
Affiliations
Hefter H, Samadzadeh S, Moll M Toxins (Basel). 2020; 12(11).
PMID: 33121133 PMC: 7693617. DOI: 10.3390/toxins12110677.
Clinical use of non-A botulinum toxins: botulinum toxin type C and botulinum toxin type F.
Eleopra R, Tugnoli V, Quatrale R, Rossetto O, Montecucco C, Dressler D Neurotox Res. 2006; 9(2-3):127-31.
PMID: 16785109 DOI: 10.1007/BF03033930.
[The dosage of botulinum toxin type B in adductor type spasmodic dysphonia].
Schonweiler R, Zwirner P HNO. 2004; 53(2):166-73.
PMID: 15060715 DOI: 10.1007/s00106-004-1072-6.
A capillary electrophoresis technique for evaluating botulinum neurotoxin B light chain activity.
Adler M, Shafer H, Manley H, Hackley Jr B, Nicholson J, Keller J J Protein Chem. 2003; 22(5):441-8.
PMID: 14690246 DOI: 10.1023/b:jopc.0000005459.00492.60.
Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystonia.
Figgitt D, Noble S Drugs. 2002; 62(4):705-22.
PMID: 11893235 DOI: 10.2165/00003495-200262040-00011.